MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by escalating memory impairments and the presence of two core pathologies, amyloid beta (Aβ) plaques and hyperphosphorylated tau (ptau)1–4.